Noxopharm Limited (ASX:NOX)
Australia flag Australia · Delayed Price · Currency is AUD
0.0650
-0.0020 (-2.99%)
Sep 18, 2026, 1:54 PM AEST

Noxopharm Financials Overview

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Revenue
1.431.432.822.46.015.43
Revenue Growth
-57.96%-49.40%17.52%-60.06%10.71%-3.20%
Gross Profit
-0.52-0.52-1.45-0.53-4.64-2.35
Operating Income
-3.44-3.44-5.39-4.6-10.64-9.78
Net Income
-4.46-4.46-4.88-3.58-15.06-18.67
Earnings Per Share
-0.01-0.01-0.02-0.01-0.05-0.06
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Investments
0.290.291.552.323.0114.01
Total Debt
4.574.572.48--0.16
Net Cash (Debt)
-4.28-4.28-0.922.323.0113.85
Net Cash Growth
----22.89%-78.28%-47.63%
Net Cash Per Share
-0.01-0.01-0.000.010.010.05

Cash Flow & CapEx

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Operating Cash Flow
-2.71-2.71-5.82-0.68-10.95-13.73
Capital Expenditures
------
Free Cash Flow
-2.71-2.71-5.82-0.68-10.95-13.73
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Gross Margin
-36.13%-36.13%-51.25%-22.28%-77.14%-43.27%
Operating Margin
-240.86%-240.86%-190.96%-191.71%-177.12%-180.14%
Pretax Margin
-312.17%-312.17%-173.15%-149.07%-250.52%-343.86%
Profit Margin
-312.17%-312.17%-173.15%-149.07%-250.52%-343.86%
FCF Margin
-190.06%-190.06%-206.48%-28.51%-182.13%-252.98%

Valuation

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PS Ratio
14.4218.735.598.042.0910.50